Correlation Between Regencell Bioscience and DaVita HealthCare

Can any of the company-specific risk be diversified away by investing in both Regencell Bioscience and DaVita HealthCare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regencell Bioscience and DaVita HealthCare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regencell Bioscience Holdings and DaVita HealthCare Partners, you can compare the effects of market volatilities on Regencell Bioscience and DaVita HealthCare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regencell Bioscience with a short position of DaVita HealthCare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regencell Bioscience and DaVita HealthCare.

Diversification Opportunities for Regencell Bioscience and DaVita HealthCare

-0.05

Correlation Coefficient

Regencell Bioscience  DaVita HealthCare

Good diversification

The 3 months correlation between Regencell and DaVita is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Regencell Bioscience Holdings and DaVita HealthCare Partners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DaVita HealthCare and Regencell Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regencell Bioscience Holdings are associated (or correlated) with DaVita HealthCare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DaVita HealthCare has no effect on the direction of Regencell Bioscience i.e., Regencell Bioscience and DaVita HealthCare go up and down completely randomly.

Pair Corralation between Regencell Bioscience and DaVita HealthCare

Considering the 90-day investment horizon Regencell Bioscience Holdings is expected to under-perform the DaVita HealthCare. In addition to that, Regencell Bioscience is 2.79 times more volatile than DaVita HealthCare Partners. It trades about -0.1 of its total potential returns per unit of risk. DaVita HealthCare Partners is currently generating about 0.15 per unit of volatility. If you would invest  13,687  in DaVita HealthCare Partners on March 7, 2024 and sell it today you would earn a total of  816.00  from holding DaVita HealthCare Partners or generate 5.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Regencell Bioscience Holdings  vs.  DaVita HealthCare Partners

Regencell Bioscience

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Regencell Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point.

DaVita HealthCare

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in DaVita HealthCare Partners are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, DaVita HealthCare may actually be approaching a critical reversion point that can send shares even higher in July 2024.

Pair Trading with Regencell Bioscience and DaVita HealthCare

The main advantage of trading using opposite Regencell Bioscience and DaVita HealthCare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regencell Bioscience position performs unexpectedly, DaVita HealthCare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DaVita HealthCare will offset losses from the drop in DaVita HealthCare's long position.

The idea behind Regencell Bioscience Holdings and DaVita HealthCare Partners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.